These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 26561332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M.
    Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.
    Inoue Y, Okada Y, Shinohara M, Kobayashi T, Kobayashi T, Tomomasa T, Takeuchi K, Morikawa A.
    J Pediatr; 2006 Sep; 149(3):336-341. PubMed ID: 16939743
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of Yersinia Infection With Kawasaki Disease: A Prospective Multicenter Cohort Study.
    Hayashi H, Uda K, Araki Y, Akahoshi S, Tanaka M, Miyata K, Hataya H, Miura M.
    Pediatr Infect Dis J; 2023 Dec 01; 42(12):1041-1044. PubMed ID: 37725804
    [Abstract] [Full Text] [Related]

  • 9. Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant.
    Okada S, Azuma Y, Suzuki Y, Yamada H, Wakabayashi-Takahara M, Korenaga Y, Akase H, Hasegawa S, Ohga S.
    Pediatr Int; 2016 Apr 01; 58(4):295-8. PubMed ID: 26670024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study.
    Teraguchi M, Ogino H, Yoshimura K, Taniuchi S, Kino M, Okazaki H, Kaneko K.
    Pediatr Cardiol; 2013 Apr 01; 34(4):959-63. PubMed ID: 23184018
    [Abstract] [Full Text] [Related]

  • 13. Yersinia pseudotuberculosis Infection Accompanied by Intussusception and Incomplete Kawasaki Disease in a 7-year-old Girl.
    Ohnishi T, Nakazawa M, Wada N, Abe J, Kamimaki I.
    Keio J Med; 2022 Jun 25; 71(2):50-52. PubMed ID: 34108299
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kawasaki disease caused by Yersinia pseudotuberculosis infection.
    Ono Y, Watari T, Nakashima S, Suemitsu K, Okamura R, Taketani T.
    QJM; 2020 Sep 01; 113(9):679-680. PubMed ID: 32186733
    [No Abstract] [Full Text] [Related]

  • 16. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
    Lo MS, Newburger JW.
    Int J Rheum Dis; 2018 Jan 01; 21(1):64-69. PubMed ID: 29205910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Standard-dose and short-term corticosteroid therapy in immunoglobulin-resistant Kawasaki disease.
    Takeshita S, Kawamura Y, Nakatani K, Tsujimoto H, Tokutomi T.
    Clin Pediatr (Phila); 2005 Jun 01; 44(5):423-6. PubMed ID: 15965549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.